Divigel

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone medications that may include: Synthetic hormones (like medroxyprogesterone acetate) or Horse-derived estrogens (like Premarin, from pregnant mare urine) Consistent, tested dosing Bioidentical Hormones Hormones chemically identical to those your body naturally produces, derived from plant sources (soy/yams). Two Categories of Bioidentical Options FDA-Approved Bioidentical Products (generally recommended) Estradiol patches – Vivelle-Dot, Climara Estradiol gels – EstroGel, Divigel Progesterone – Prometrium (oral capsule) These have standardized dosing and safety testing Compounded Bioidentical Hormones (more controversial) Custom-mixed by compounding pharmacies Often marketed as "natural" and personalized Not FDA-approved for safety/efficacy Quality can vary significantly between pharmacies Key Considerations FDA-approved bioidentical options offer the best of both worlds - natural molecular structure with proven safety data Most major medical organizations do not recommend compounded versions over regulated alternatives Always consult an endocrinologist or menopause specialist for personalized guidance The marketing around "bioidentical" can be misleading - FDA-approved options are your safest starting point.

Mentioned in position 5 of 6

Short answer BHRT = bioidentical hormone replacement therapy. It means giving hormones that are chemically identical to the hormones your body makes (for example 17β‑estradiol, progesterone, testosterone) to treat symptoms of hormone deficiency. Whether you “need” it depends on your symptoms, medical history, and risks — discuss this with a clinician. What BHRT is (brief) “Bioidentical” refers to the chemical structure being the same as human hormones (not necessarily that it’s safer). BHRT can be delivered as FDA‑approved products (estradiol patches, micronized progesterone capsules, transdermal testosterone products, vaginal estrogen tablets/creams/rings) or as custom‑compounded preparations (creams, pellets, troches). Common targets: menopausal/perimenopausal symptoms (hot flashes, night sweats), vulvovaginal atrophy, sexual dysfunction, and symptomatic low testosterone in men. When BHRT might help Moderate–severe vasomotor symptoms (hot flashes/night sweats) that affect quality of life. Genitourinary syndrome of menopause (vaginal dryness, painful intercourse) — local vaginal estrogen often works well. Premature ovarian insufficiency or surgical menopause (younger people often benefit from hormonal replacement). Men with documented symptomatic low testosterone (confirmed by morning labs and appropriate evaluation). How clinicians decide (testing and assessment) Start with a symptom history, menstrual pattern/age, and medical risk assessment (breast cancer history, clotting disorders, CVD, liver disease, etc.). Common labs: for women — FSH and estradiol (sometimes); for men — morning total testosterone, maybe free testosterone, LH, prolactin, PSA and hematocrit before/during therapy. Beware: saliva hormone tests are not reliable for guiding systemic therapy; blood tests are preferred. You don’t always need labs if a woman is >50 with classic menopausal symptoms; labs are more helpful in atypical cases or younger patients. Benefits vs risks (important) Benefits: relief of hot flashes, improved sleep/mood for some people, vaginal symptom relief, prevention of bone loss if indicated. Risks: similar to conventional HRT — possible increased risk of thromboembolism, stroke, and (depending on hormone type and duration) breast cancer; risk depends on age, dose, route (transdermal estrogen has lower VTE risk than oral), and whether progesterone is used in women with a uterus. Compounded BHRT has less regulatory oversight and variable dosing/purity; safety and efficacy data are more limited. Pellet therapy and unmonitored dosing are associated with higher adverse-event concerns in some reports. Practical guidance — how to proceed Make an appointment with a clinician experienced in menopause or hormone therapy (OB/GYN, reproductive endocrinologist, internist trained in menopause). You can search for a NAMS Certified Menopause Practitioner (NCMP) through the North American Menopause Society (NAMS). Discuss symptoms, medical history, and your goals. Ask about nonhormonal options if you have contraindications. If hormone therapy is appropriate, prefer FDA‑approved, standard formulations first (they have known dosing, quality control, and safety data). Consider transdermal estradiol if you have clotting risk. If considering compounded BHRT, ask why a standard FDA product won’t work, insist on blood testing (not saliva) and on using a reputable, licensed compounding pharmacy that follows USP standards. Be aware of limited oversight and evidence. Specific products and resources (examples) FDA‑approved bioidentical options: estradiol patches (Vivelle‑Dot, Climara), estradiol gels (EstroGel, Divigel), vaginal products (Vagifem tablets, Estrace cream, Estring ring), micronized progesterone (Prometrium). For male testosterone replacement: AndroGel, Testim, Axiron (prescription testosterone products — use requires proper testing and monitoring). Trusted information and clinician search: North American Menopause Society (menopause.org), Endocrine Society guidelines, Mayo Clinic and Cleveland Clinic patient pages. Labs: common national labs (Quest Diagnostics, LabCorp) for reliable serum testing. When not to use BHRT Active, untreated breast cancer or certain other estrogen‑sensitive cancers, active blood clots, unexplained vaginal bleeding, pregnancy. Decisions should be individualized for people with history of breast cancer — discuss risks with an oncologist. If you want next steps Tell me: your age, sex, main symptoms, any major medical history (breast cancer, clotting, heart disease), and whether you’ve had any hormone tests — I can suggest what to ask your clinician and which labs would be reasonable.

Mentioned in position 4 of 14